APA (7th ed.) Citation

Greco, M., Gebbia, V., Berardi, R., Usset, A., Ricciardi, G., La Verde, N., . . . Valerio, M. R. (2026). A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy. Cancers, 18(13), 2042. https://doi.org/10.3390/cancers18132042

Chicago Style (17th ed.) Citation

Greco, Martina, et al. "A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy." Cancers 18, no. 13 (2026): 2042. https://doi.org/10.3390/cancers18132042.

MLA (9th ed.) Citation

Greco, Martina, et al. "A Real-World Study on the Effectiveness and Safety of Elacestrant in Patients with ESR1 -Mutated Metastatic Breast Cancer Progressing After CDK4/6 Inhibitors and Endocrine Therapy." Cancers, vol. 18, no. 13, 2026, p. 2042, https://doi.org/10.3390/cancers18132042.